Foto del docente

Arrigo Francesco Giuseppe Cicero

Professore associato

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: MEDS-08/C Scienza dell’alimentazione e delle tecniche dietetiche applicate

Direttore Scuola di Specializzazione Scienza dell'Alimentazione (68/2015)

Pubblicazioni

Raschi E, Casula M, Cicero AFG, Corsini A, Borghi C, Catapano A., Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events., «PHARMACOLOGY & THERAPEUTICS», 2023, 250, Article number: 108507, pp. 1 - 20 [articolo]Open Access

Bolat S, Ertürk Zararsız G, Doğan K, Kochan N, Yerlitaş SI, Cephe A, Zararsız G, Cicero AFG, Concordance of LDL-C Estimating Equations with Direct Enzymatic Measurement in Diabetic and Prediabetic Subjects, «JOURNAL OF CLINICAL MEDICINE», 2023, 12, Article number: 3570, pp. 1 - 19 [articolo]Open Access

Bauer R, Cicero AFG, Manca M, Editorial: Data driven and model based computational futures in cardiovascular practice, «FRONTIERS IN CARDIOVASCULAR MEDICINE», 2023, 10, Article number: 1336340, pp. 1 - 2 [articolo]Open Access

Hu Y; Cicero AFG., Editorial: Serum uric acid, vascular aging, and endocrine comorbidities, «FRONTIERS IN ENDOCRINOLOGY», 2023, 14, Article number: 1292015, pp. 1 - 2 [articolo]Open Access

Fogacci, F.; Veronesi, M.; Micoli, A. D.; Bove, M.; Cicero, A. F. G., Effect of a combined mulberry-sage dietary supplement on food craving and body weight: a pilot clinical trial, «PROGRESS IN NUTRITION», 2023, 25, Article number: e2023047, pp. 1 - 4 [articolo]

Pierdomenico M, Cicero AFG, Veronesi M, Fogacci F, Riccioni C, Benassi B, Effect of Citrus bergamia extract on lipid profile: A combined in vitro and human study, «PHYTOTHERAPY RESEARCH», 2023, 37, pp. 4185 - 4195 [articolo]Open Access

Fogacci F, Degli Esposti D, Di Micoli A, Fiorini G, Veronesi M, Borghi C, Cicero AFG., Effect of dietary supplementation with Diuripres® on blood pressure, vascular health, and metabolic parameters in individuals with high-normal blood pressure or stage I hypertension: The CONDOR randomized clinical study, «PHYTOTHERAPY RESEARCH», 2023, 37, pp. 4851 - 4861 [articolo]Open Access

Ehlrich A, Ioannidis K. Nasar M., Alkian IA, Daskal Y, Atari N, Kliker L, Rainy N, Hofree M, Tikva SS, Houri I, Cicero AF, Pavanello C, Sirtori CI, CohenJB, Chirinos JA, Deutsch L, Cohen M, Gottlieb A, Bar-Chaim A, Shibolet O, Mandelboim M, Maayan S, Nahmias Y., Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study, «ELIFE», 2023, 12, Article number: e79946, pp. 1 - 36 [articolo]Open Access

Cicero, A. F. G.; Fogacci, F.; Giovannini, M.; Grandi, E.; D'Addato, S.; Borghi, C., Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting, «BIOMEDICINES», 2023, 11, Article number: 3289, pp. 1 - 12 [articolo]Open Access

Fogacci, F; Giovannini, M; Di Micoli, V; Grandi, E; Veronesi, M; Borghi, C; Cicero, ARRIGO FRANCESCO GIUSEPPE, Evaluation of the effect of a dietary supplementation with a red yeast rice and fish oil-containing nutraceutical on lipid pattern, high sensitivity C-reactive protein, and endothelial function in moderately hypercholesterolaemic subjects: a double-blind, placebo-controlled, randomized clinical trial., «ARCHIVES OF MEDICAL SCIENCES. ATHEROSCLEROTIC DISEASES», 2023, 8, pp. 182 - 189 [articolo]

Palatini P, Virdis A, Masi S, Mengozzi A, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, Parati G, Rivasi G, Salvetti M, Barbagallo CM, Bombelli M, Dell'Oro R, Bruno B, Lippa L, D'Elia L, Masulli M, Verdecchia P, Reboldi G, Angeli F, Mallamaci F, Cirillo M, Rattazzi M, Cirillo P, Gesualdo L, Mazza A, Giannattasio C, Maloberti A, Volpe M, Tocci G, Iaccarino G, Nazzaro P, Galletti F, Ferri C, Desideri G, Viazzi F, Pontremoli R, Muiesan ML, Grassi G, Borghi C; from the Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA)., Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level., «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2023, 33, pp. 323 - 330 [articolo]

Fogacci F, Borghi C, Davinelli S, Scapagnini G, Cicero AFG., Impact of anti-oestrogen therapy on lipoprotein(a) in postmenopausal women: a systematic review and meta-analysis of double-blind placebo-controlled clinical studies., «ENDOCRINE», 2023, 80, pp. 292 - 302 [articolo]

Poli A, Catapano AL, Corsini A, Manzato E, Werba JP, Catena G, Cetin I, Cicero AFG, Cignarella A, Colivicchi F, Consoli A, Landi F, Lucarelli M, Manfellotto D, Marrocco W, Parretti D, Perrone Filardi P, Pirillo A, Sesti G, Volpe M, Marangoni F, LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals, «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2023, 33, pp. 245 - 257 [articolo]Open Access

Fogacci F, Giovannini M, Imbalzano E, Grandi E, Rizzoli E, D'Addato S, Cicero AFG, Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial, «ARCHIVES OF MEDICAL SCIENCE», 2023, 19, pp. 1228 - 1235 [articolo]Open Access

Risoli S, Nali C, Sarrocco S, Cicero AFG, Colletti A, Bosco F, Venturella G, Gadaleta A, Gargano ML, Marcotuli I., Mushroom-Based Supplements in Italy: Let’s Open Pandora’s Box, «NUTRIENTS», 2023, 15, Article number: 776, pp. 1 - 14 [articolo]Open Access

Ultimi avvisi

Al momento non sono presenti avvisi.